Morning Breakouts

Latest KFF Health News Stories

Family Planning Spending Cuts Will Lead To ‘More Unwanted’ Pregnancies, ‘Unsafe Abortions’

Morning Briefing

“Unwanted babies and unsafe abortion are major problems in the developing world, yet funding for contraception is limited because of attitudes to sex and abortion in donor countries,” the Guardian’s Sarah Boseley writes in her “Global Health Blog.” She reflects on her time spent in Dakar, Senegal, last week for the 2nd International Conference on Family Planning, and writes that, “in francophone Africa …, only 10 percent of women have access to what are called modern methods of family planning,” such as hormonal contraceptive injections or pills.

Gingrich’s Policy Positions Draw Attention As His Popularity Grows

Morning Briefing

The Boston Globe examines how Gingrich’s view of the individual mandate has changed. Meanwhile, Reuters reports on GOP presidential hopeful Mitt Romney’s efforts to keep his record as governor of Massachusetts under wraps. Finally, Rick Santorum gets into a health policy fracas in Iowa.

USA Today: $1.5 Billion In Medicare Prescription Drug Savings

Morning Briefing

USA Today notes that the government is expected to announce today that the health law’s Medicare doughnut hole provision triggered this savings. In other Medicare news, the federal government announced Monday that Medicare will allow its claims database to be used by employers, insurance companies and consumer groups.

A Changing Of The Guard At CMS

Morning Briefing

CQ HealthBeat reports on the new head of the Centers for Medicare and Medicaid Services, while other news outlets report on the outgoing administrator’s thoughts on the job and the system.

Multiple-Employer Health Plans To Face Quick Enforcement Procedures

Morning Briefing

Under a proposed rule stemming from the health law, the secretary of labor will have enforcement tools designed to protect employers, providers and wokers from mismanaged or fraudulent multiple-employer welfare arrangements.

Comparative-Effectiveness Research Takes Center Stage

Morning Briefing

The Patient-Centered Outcomes Research Institute attracted a larger-then-expected volume of applications for its pilot projects grants program. Meanwhile, the institute, which was created by the health law, will release its draft agenda next month.

Legislative Update: Congressional Health Bills Draw Attention

Morning Briefing

New legislation was introduced to make drug price gouging a federal crime. Also, a measure is pending that seeks to make the upcoming Supreme Court term “must-see TV.” The abortion battle will heat up again in a hearing scheduled today over the Prenatal NonDiscrimination Act.

Still On The Capitol Hill To-Do List: Payroll Tax Holiday Extension, Medicare Doc Fix

Morning Briefing

Reuters terms the tasks “issues affecting Americans’ pocketbook.” The outstanding questions include how to pay for the payroll tax break extension – could Medicare offer some ideas? Also, could the doc fix fight spill over into January?

New Global Map Shows Difficult-To-Treat Malaria Strain Remains Prevalent In Asia, Latin America

Morning Briefing

“Declining malaria deaths in Africa and progress toward an effective malaria vaccine are raising hopes the disease will soon be eradicated worldwide,” but “researchers at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Philadelphia, Pennsylvania, [on Monday] unveiled a new global malaria map that raises new concerns about the disease,” VOA News writes (Sinha, 12/5). The researchers from Britain’s Oxford University mapped the Plasmodium vivax malaria parasite, “which is often recurring and can be deadly,” and found it is “endemic in substantial parts of the world,” particularly in Asia and Latin America, Reuters writes (Kelland, 12/5).

Fake, Poor-Quality Drugs Boosting Malaria Drug Resistance In Southeast Asia, U.S. Experts Say

Morning Briefing

“Fake or poor quality malaria drugs are boosting resistance in parts of southeast Asia, a problem that is likely to worsen unless tighter regulations are adopted, U.S. experts said Monday” at a hearing of the House Foreign Affairs Subcommittee on Africa, Global Health, and Human Rights, Agence France-Presse reports. “‘Drug resistance to the most effective drug available, artemisinin-based combination therapy, is developing and has been recognized in southeast Asia,'” Regina Rabinovich, director of infectious diseases at the Bill & Melinda Gates Foundation, said, according to the news service.